Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04430842
Title	Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Quadriga Biosciences, Inc.
Indications	ovarian cancer sarcoma head and neck cancer esophageal cancer malignant pleural mesothelioma liver cancer cholangiocarcinoma thymic carcinoma melanoma kidney cancer brain cancer colorectal cancer tongue cancer cervical cancer prostate cancer Advanced Solid Tumor lung cancer breast cancer urinary bladder cancer pancreatic cancer stomach cancer
Therapies	QBS10072S
Age Groups:	adult \| senior
Covered Countries	AUS

Facility	Status	City	State	Zip	Country	Details
St George Private Hospital		Kogarah	New South Wales	2217	Australia	Details
Sydney Southwest Private Hospital		Liverpool	New South Wales	2170	Australia	Details

*Shaded cells indicate that there was no data available from clincialtrials.gov for the field